Goodwin
Andrea Akinbola
- Deals
- 4
- Latest
- Apr 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 4 deals
Often works with
- Daniel Karelitz 4 deals together
- Arman Oruc 4 deals together
- Simone Waterbury 3 deals together
- Katerina Stavrianidis 3 deals together
- Matthew Wetzel 3 deals together
- Felipe M. Heiderich 2 deals together
- Wei Xu 2 deals together
- Bill Collins 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Apr 2026 | Obsidian Therapeutics | – | – | Placement | Legal adviser to Obsidian Therapeutics | Completed | 350.0 | Biotech+2 | Obsidian Therapeutics placement |
| Apr 2026 | Obsidian Therapeutics | – | Galera Therapeutics | Merger | Legal adviser to Obsidian Therapeutics | Completed | 413.5 | Biotech+2 | Galera Therapeutics and Obsidian Therapeutics merger |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Ouro Medicines (target) | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Orna Therapeutics (target) | Announced | 2,400.0 | Biotech+1 | Eli Lilly and Company acquisition of Orna Therapeutics |
Deals where Andrea Akinbola is named on the firm's deal team, by the firm or the press.